In Brief: Roche Posicor
Executive Summary
Roche Posicor: Calcium channel blocker recommended for approval for treatment of hypertension and chronic stable angina by a 5-3 vote of FDA's Cardiovascular & Renal Drugs Advisory Committee Feb. 28. Committee members supporting the recommendation agree that concerns about cardiac repolarization should not limit Posicor (mibefradil) to second-line use...